‘Med error didn't hit patient, no payout'
After regaining consciousness, she complained that her big toe had not been corrected; the second toe was elevated and deviating; and there was complete numbness in her left foot. She was informed that these were temporary effects due to incision and anaesthesia. She was discharged after two days before the wounds had healed. Subsequently, a proper dressing was done during followup, but Rastogi claimed that her condition had worsened due to fluid leakage and crusted fluid around the scars.
She remained in pain for months and was dependent on painkillers due to the screw implanted in her joint, which continued to cause distress until it was eventually removed by another specialist. She also pointed out that negligence was clear as her blood group was recorded as O +ve even though it was O -ve. So she alleged negligence and deficiency in service. The hospital and the surgeon denied the allegations, stating that accepted medical practices had been followed while conducting the procedure.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
American Investor Warren Buffett Recommends: 5 Books For Turning Your Life Around
Blinkist: Warren Buffett's Reading List
Undo
The intended correction was limited only to the big toe, and had been achieved. The deformity in the second toe was already present prior to surgery, but it became more conspicuous after the correction of the big toe, and this had been explained during the preoperative counselling and consent process. . The Commission noted that the proper procedure had been followed after explaining the risks and obtaining informed consent.
Also, there was no negligence in postoperative care. As regards the incorrect blood group, the Commission held that there was no actionable negligence.
You Can Also Check:
Mumbai AQI
|
Weather in Mumbai
|
Bank Holidays in Mumbai
|
Public Holidays in Mumbai
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Navi Mumbai hill quarry blasts endanger Tata cancer hospital
Navi Mumbai: The blasting activities at Kharghar Hill quarry have affected the Tata Cancer Hospital's functioning, besides causing distress to patients. The director of the Advanced Centre for Treatment, Research & Education in Cancer (ACTREC) has made an urgent appeal to the chief minister for intervention. The tehsildar has confirmed the quarry's lack of proper authorisation. The unlawful quarrying activities near Tata Cancer Hospital at Kharghar Hills, reportedly run by politicians and quarry operators, have resulted in damage to the hospital's buildings. These operations pose risks to patients and valuable medical equipment. The ACTREC director, Dr Pankaj Chaturvedi, in his letter to the CM stated, "It's the health of the patients that is more important and which is invisible and non-negotiable. The northwest hill near our cancer treatment facility has been severely impacted, with multiple pits excavated and green cover obliterated." You Can Also Check: Mumbai AQI | Weather in Mumbai | Bank Holidays in Mumbai | Public Holidays in Mumbai The continuous blasting and drilling operations produce excessive noise and dust pollution, jeopardising patient wellbeing and environmental health. Dr Chaturvedi has sought immediate governmental action to halt these "destructive" quarrying activities and explore sustainable alternatives. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like This Could Be the Best Time to Trade Gold in 5 Years IC Markets Learn More Undo He stressed the necessity of safeguarding cancer patients' health and welfare, protecting biodiversity, and maintaining eco-sensitive areas. An RTI query by Mumbai-based NGO NatConnect Foundation revealed that the quarry was operating without government approval. NatConnect director, B N Kumar, brought the matter to the chief minister's attention, who referred it to Raigad's district collector. Following a 2018 NGT ruling regarding Parsik Hill quarrying, environmental clearance is required for such operations. Dr Chaturvedi informed the CM about structural damage to 25-year-old hospital buildings, including cracked beams and slabs, weakening ACTREC campus structures. The deterioration has led to water infiltration during rains, causing fungal growth in cleanroom facilities and increasing patient risks. Dr Chaturvedi highlighted serious concerns about rising noise and dust pollution from uncontrolled quarrying adjacent to ACTREC. These ongoing activities have virtually destroyed a previously verdant hill. The dust affects residential sectors 22, 30, and 35, contaminating the hospital's sterile treatment areas. This creates considerable risks for vulnerable patients receiving crucial treatments like bone marrow transplants and proton therapy. Equipment requiring sterile environments faces persistent contamination risks. Dr Chaturvedi pointed out the quarrying operations' proximity to Pandavkada Waterfalls, an eco-tourism site, and the upcoming Kharghar-Turbhe tunnel. Jyoti Nadkarni from the Kharghar Hill and Wetlands forum noted regular observations of dump trucks transporting stones from the quarry area.
Time of India
2 hours ago
- Time of India
Punjab increases monthly stipends for medical and dental college interns, residents
1 2 3 Chandigarh: Punjab finance minister Harpal Singh Cheema on Thursday announced an increase in the monthly stipends for interns, junior residents, and senior residents across govt medical and dental colleges in the state. The finance minister said there are currently 907 sanctioned intern posts, 1,408 for junior residents, and 754 for senior residents within Punjab's govt medical and dental colleges. The stipend for interns has been substantially raised from Rs 15,000 to Rs 22,000 per month. For junior residents, the new stipend structure will see a rise from the current Rs 67,968 per month to Rs 76,000 in the first year, Rs 77,000 in the second year, and Rs 78,000 in the third year. Similarly, senior residents will experience an increase from their current Rs 81,562 per month to Rs 92,000 in the first year, Rs 93,000 in the second year, and Rs 94,000 in the third year. Cheema reiterated the state govt's dedication to allocating ample resources for the education and health sectors. He said that the annual expenditure on these stipends, currently Rs 204.96 crore, will escalate to Rs 238.18 crore following this enhancement, representing an estimated annual increase of Rs 33.22 crore. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like You Won't Believe the Price of These Dubai Apartments Binghatti Developers FZE Get Offer Undo The finance minister affirmed the Punjab govt's resolve to enhance healthcare facilities throughout the state. He also mentioned the recent initiative to provide insurance coverage of Rs 10 lakh to every citizen, further emphasising the govt's focus on public welfare. Cheema assured that there will be no scarcity of funds for the continued development and improvement of healthcare infrastructure and services in Punjab. MSID:: 122881701 413 |
Time of India
2 hours ago
- Time of India
Federal heat on UnitedHealth sends shares tumbling — what you need to know
UnitedHealth Group Inc. (NYSE: UNH) saw its stock tumble nearly 4% today, continuing a steep downward spiral that has erased over 40% of its value in 2025 alone. The latest drop comes after the company confirmed that it's under both criminal and civil investigation by the U.S. Department of Justice (DOJ), related to its Medicare Advantage billing practices. How much has UnitedHealth stock lost in 2025? UnitedHealth stock has been among the worst performers on the S&P 500 this year. After starting 2025 near $525 per share, the stock has plummeted below $300, marking a more than 40% year-to-date drop. Key moments behind the plunge: by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like War Thunder - Register now for free and play against over 75 Million real Players War Thunder Play Now Undo April 2025 : Stock dropped 22% in a single day after missing Q1 earnings and slashing full-year guidance. May 2025 : CEO Andrew Witty resigned, adding leadership instability to the mix. July 2025 : Confirmation of DOJ investigation triggers renewed selling pressure. UnitedHealth Under DOJ Investigation: What's Going On? The Department of Justice (DOJ) is officially investigating UnitedHealth Group—America's largest health insurer—over its Medicare Advantage billing. The federal probes focus on whether the company artificially inflated patient risk scores to receive higher reimbursements from the government. Live Events UnitedHealth has confirmed receiving requests for information from the DOJ and stated it is cooperating fully with both criminal and civil investigations. While the company initially denied any criminal probe, it now admits it had proactively reached out to federal authorities earlier this year to clarify billing procedures and launch internal reviews. The DOJ's primary concern is centered on risk adjustment coding—a process that determines how much money the federal government pays insurers like UnitedHealth based on patients' medical conditions. Allegations suggest the company may have exaggerated diagnoses to collect excess payments from Medicare. How Did the Market React? As soon as news of the investigation surfaced, UnitedHealth stock took a hit . Shares fell over 4% in premarket trading , extending a broader decline that's seen the stock drop more than 40% year-to-date . This is not an isolated event. Earlier this year, UnitedHealth's stock experienced a major downturn when its former CEO unexpectedly resigned and the company withdrew its 2025 earnings guidance , citing cost overruns tied to its Medicare Advantage business. The current legal troubles are piling onto existing financial pressures, sending a clear message to investors: the road ahead may be rocky. The Core Issue: Medicare Advantage Risk Adjustment At the heart of the investigation is Medicare Advantage, a privately managed health insurance program funded by the federal government. Insurers like UnitedHealth receive payments based on the health risk profiles of their enrollees. The more serious the health conditions of a patient, the higher the risk score—and the larger the government payout. However, the DOJ is now investigating whether UnitedHealth manipulated these scores by inflating patient diagnoses. This isn't a new concern in the industry. Other insurers have faced similar audits and lawsuits. However, given UnitedHealth's size and influence, the implications could be significantly larger. Is it time to buy the dip on UnitedHealth stock? This is the big question facing investors. UNH stock may look cheap relative to historical valuation, but headline risk remains high . Here are two opposing scenarios: Bull Case: DOJ investigation ends with a manageable settlement. Medical cost inflation stabilizes. Leadership transition brings strategic clarity. Bear Case: Legal issues expand and trigger major fines or contract losses. Costs continue rising, forcing more earnings cuts. Institutional investors exit further, adding pressure. UnitedHealth's Response: Transparency, Audits & Reforms In response to the federal heat, UnitedHealth has taken several steps to present itself as compliant and transparent: Voluntary Disclosures : The company claims it initiated contact with the DOJ months ago and is cooperating with all requests. Third-party Audits : UnitedHealth says it is conducting external reviews of its risk adjustment processes, possibly signaling internal reforms are underway. Compliance Enhancements : The insurer is working on strengthening its internal controls to ensure billing accuracy going forward. Despite these efforts, legal experts suggest that even if no wrongdoing is found, the very existence of a federal investigation could lead to increased regulatory oversight, reputational damage, and mounting legal expenses. Other Headwinds Facing UnitedHealth The DOJ probe comes at a time when UnitedHealth is already navigating several internal and external challenges: 1. Leadership Shake-Up In May, longtime CEO Andrew Witty stepped down unexpectedly amid the growing storm. Former CEO Stephen Hemsley returned to stabilize the company and restore investor trust. 2. Rising Medical Costs Healthcare utilization surged in recent quarters, leading to higher-than-expected medical costs. UnitedHealth has warned of increased pressure on margins due to greater demand for surgeries, outpatient care, and chronic condition treatments. 3. Public Perception & Legal Risks Alongside regulatory attention, UnitedHealth is facing public scrutiny. If the DOJ finds grounds for prosecution, the company could face heavy fines, tighter compliance mandates, or even restrictions on future government contracts. Impact on Investors: What You Should Know For investors, the combination of legal risk, leadership uncertainty, and financial strain creates a complex risk profile. Key Concerns: Shareholder Value : With shares down over 40% YTD, portfolio exposure is already taking a hit. Earnings Outlook : With the company pulling its 2025 forecast, investors are left without clarity on future earnings potential. Regulatory Uncertainty : Prolonged investigations may drag down sentiment and stock performance even if no wrongdoing is proven. While some see the current dip as a buying opportunity in a fundamentally strong company, others warn that further volatility is likely in the coming quarters. What's Next: Timeline to Watch Upcoming Milestones: Earnings Report (Early August) : Investors are eagerly awaiting the next quarterly results. The focus will be on legal disclosures, medical cost trends, and updated guidance. DOJ Progress Updates : Any new details about the investigation's scope, possible subpoenas, or charges could further affect stock movement. Organizational Changes : Investors will also watch for more leadership reshuffles or board-level changes aimed at regaining market trust. Should You Be Worried? The UnitedHealth DOJ investigation is a serious matter—not just for the company, but for the broader health insurance industry. While the company has made moves toward transparency and reform, the federal probe introduces significant uncertainty around both earnings and regulatory compliance. If you're an investor, this is a moment to remain informed and cautious. Watching how the company navigates the legal, financial, and reputational fallout will be critical in determining whether UnitedHealth can regain its footing—or if deeper troubles lie ahead. FAQs: Q1: Why is UnitedHealth under DOJ investigation? The DOJ is probing UnitedHealth for possibly overbilling Medicare Advantage through inflated diagnoses. Q2: How did the DOJ probe affect UnitedHealth stock? UnitedHealth stock fell sharply after the DOJ launched its criminal and civil investigations.
